Shannon Perrine from WTAE, Pittsburgh’s Action News Four, the local ABC affiliate, visited our research and development lab in Pittsburgh for a feature about how Predictive Oncology is making a meaningful difference in the development of cancer drugs on a global scale. She highlighted the important work we’re doing to expedite drug discovery and how we are the only company that can pair patient heterogeneity with AI to determine how cancer drugs work on real human tumor tissue before clinical trials.

Predictive Oncology
Accepting new applications for ACE program 2025
Following the generation of successful results with the University of Michigan through the ACE program, Predictive Oncology is now actively calling for submissions for a